Trials / Sponsors / Synermore Biologics (Suzhou) Co., Ltd.
Synermore Biologics (Suzhou) Co., Ltd.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Real World Evidence Study of SYN023 in Children Exposed to Rabies Rabies Post-exposure Prophylaxis | — | 2025-08-02 |
| Completed | SYN023 With Rabies Vaccine in Healthy Pediatric Subjects Rabies Post-exposure Prophylaxis | Phase 1 | 2024-11-30 |
| Completed | A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety Rabies, Communicable Disease, Virus Diseases | Phase 3 | 2020-09-23 |
| Completed | A Bridging Study of the SYN023 on Healthy Adult Subjects Communicable Disease Transmission, Zoonotic Disease, Rabies Human | Phase 1 / Phase 2 | 2019-02-26 |